KOWIESKI MARK (Chief Financial Officer) received a stock award from EVOKE PHARMA INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/24/2025ACC: 0000950170-25-043880
Officer· Chief Financial Officer
Since May 2024
+4.50K
Net shares
Net buyer
$14.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.50K
Price / share
$3.21
Trade value
$14.46K
% of position
1081.7%
3/20/2025
416.00→4.92K
Total
Net shares
+4.50K
Net value
$14.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2025 | A · Award | +4.50K | $3.21 | $14.46K | 1081.7% | 416.00 | 4.92K |
| Total | +4.50K | $14.46K | ||||||
Derivative Transactions0
No derivative transactions reported